Search Results - BC Cancer Agency Library

ISAAC : interactive symptom assessment and collection : patient information

https://bccalibrary.andornot.com/en/permalink/catalog17675

BC Cancer Agency. [Victoria, BC?]: BC Cancer Agency , 2008.

Audience: Patient or Public

Corporate Author: BC Cancer Agency

Place of Publication: [Victoria, BC?]

Publisher: BC Cancer Agency

Publication Date: 2008

Subjects: Data Collection; Questionnaires; Patients; Computers; Neoplasms - complications; Neoplasms - psychology; Signs and Symptoms; Nursing Assessment - methods; Edmonton Symptom Assessment Scale; Quality of Life; Severity of Illness Index; BC Cancer Agency; Popular Work

Language: English

Material Type: Other

Audience: Patient or Public

Location: Victoria Library

Understanding prostate cancer : general level

https://bccalibrary.andornot.com/en/permalink/catalog9596

Oncology Interactive Education Series, Jack Digital Productions, Princess Margaret Hospital. [Toronto, ON]: Jack Digital Productions Inc. , 2001.

Audience: Patient or Public

Call Number: WJ752 U55o 2001

Availability: 2 copies, 2 available

Alternate Title: General level : comprehensive content for patients, family and friends; Understanding prostate cancer : general and clinical levels

Corporate Author: Oncology Interactive Education Series; Jack Digital Productions; Princess Margaret Hospital

Place of Publication: [Toronto, ON]

Publisher: Jack Digital Productions Inc.

Publication Date: 2001

Subjects: Prostatic Neoplasms; Popular Work

ISBN: 155344180X

Language: English

Material Type: CD ROM

Audience: Patient or Public

Location: Abbotsford Cancer Info Ctr

Call Number: WJ752 U55o 2001

Copies

c.1 BC Cancer Agency ARHCC Cancer Info Ctr			Available
c.1 BC Cancer Agency ARHCC Cancer Info Ctr			Available

Patient's guide to understanding non-small cell lung cancer

https://bccalibrary.andornot.com/en/permalink/catalog14544

Aventis. Laval, PQ: Aventis Pharma Inc. , 2002.

Audience: Patient or Public

Call Number: WF658 P298 2002

Availability: 2 copies, 2 available

Corporate Author: Aventis

Place of Publication: Laval, PQ

Publisher: Aventis Pharma Inc.

Publication Date: 2002

Subjects: Carcinoma, Non-Small Cell Lung; Lung Neoplasms; Popular Work

Language: English

Material Type: Other

Audience: Patient or Public

Location: Victoria Cancer Info Ctr; Kelowna Cancer Info Ctr

Call Number: WF658 P298 2002

Copies

c.1 BC Cancer Agency KEL Cancer Info Ctr			Available
c.1 BC Cancer Agency VIC Cancer Info Ctr			Available

AstraZeneca uro-oncology : pursuing improved outcomes in prostate cancer : understanding prostate cancer

https://bccalibrary.andornot.com/en/permalink/catalog14605

Bell, David G. Mississauga, ON: AstraZeneca , 2001.

Audience: Patient or Public

Call Number: WJ752 A859a 2001

Availability: 1 copy, 1 available

Alternate Title: Understanding prostate cancer

Author: Bell, David G

Corporate Author: AstraZeneca

Place of Publication: Mississauga, ON

Publisher: AstraZeneca

Publication Date: 2001

Subjects: Prostatic Neoplasms; Pictorial Works; Popular Work

Language: English

Material Type: Other

Audience: Patient or Public

Location: Surrey Cancer Info Ctr

Call Number: WJ752 A859a 2001

Copies

c.1 BC Cancer Agency SUR Cancer Info Ctr

Available

Learning about lung cancer : treatment options

https://bccalibrary.andornot.com/en/permalink/catalog18115

Hoffmann-La Roche Limited. Mississauga, ON: Hoffmann-La Roche Limited , 2007.

Audience: Patient or Public

Availability: 1 copy, 1 available

1 lung model with education book titled "Learning about lung cancer : treatment options" and handouts titled "Understanding treatment options for lung cancer"

Alternate Title: Understanding treatment options for lung cancer

Author: Hoffmann-La Roche Limited

Place of Publication: Mississauga, ON

Publisher: Hoffmann-La Roche Limited

Publication Date: 2007

Subjects: Lung Neoplasms; Models, Anatomic; Popular Work

Abstract: 1 lung model with education book titled "Learning about lung cancer : treatment options" and handouts titled "Understanding treatment options for lung cancer"